Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000692632 | SCV000820465 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-07-11 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3095 of the SYNE1 protein (p.Ala3095Thr). This variant is present in population databases (rs398123005, gnomAD 0.01%). This missense change has been observed in individual(s) with spastic paraplegia, mild intellectual disability, axonal neuropathy, and leukoencephalopathy in a (PMID: 24123876). This variant is also known as Ala3088Thr. ClinVar contains an entry for this variant (Variation ID: 242649). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics Inc | RCV001658072 | SCV001880888 | uncertain significance | not provided | 2020-12-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001658072 | SCV003826359 | uncertain significance | not provided | 2021-11-05 | criteria provided, single submitter | clinical testing |